Quantum computing accelerating risk measure calculations for insurers, enabling faster, more accurate premium setting and reserve management through quantum amplitude estimation of expectiles and Range Value-at-Risk.

Quantum-inspired digital annealing optimizing emergency patient allocation in hospitals, reducing bottlenecks and wait times, improving patient flow, and enhancing overall healthcare efficiency.

SQUID-based MRI enabling affordable, portable imaging using weak magnetic fields, eliminating complex infrastructure. This allows early disease detection and treatment on a global scale, improving outcomes and healthcare accessibility.

Quantum optimisation and quantum machine learning can accelerate medical image analysis, improving reconstruction, classification, and neuroimaging alignment, enabling faster, more accurate diagnostics and large-scale brain studies for personalised treatment.

Quantum neural networks and solvers enabling efficient, scalable modeling of complex, nonlinear brain-genetics-behaviour dynamics, offering deeper insights for digital phenotyping and improved clinical decision-making.

A diamond-based quantum sensor tracks free radicals in real time within single mitochondria, enabling precise mapping of oxidative stress and advancing understanding of cell function, disease progression, and targeted treatment development.

Quantum sensing with NV-centre diamond magnetometry enables non-invasive protein structure and dynamics analysis under physiological conditions, revealing nanoscale details and movements, advancing disease understanding, drug design, and therapeutic target discovery.

Quantum algorithms like VQE, QAOA, and quantum annealing accelerating protein folding and drug interaction predictions, improving energy estimation, ligand docking, and aiding protein design, drug discovery, and understanding biological behavior.

Optically Pumped Magnetometers enabling wearable, high-resolution MEG without cryogenics, allowing natural movement, closer scalp measurements, and more affordable, accessible brain monitoring for research and disease prevention.

Graphene quantum dots (GQDs) enabling targeted cancer therapy via photothermal and photodynamic effects, enhancing tumour destruction while minimizing healthy tissue damage, potentially advancing precision drug delivery and personalized treatment strategies.

Quantum machine learning accelerates drug discovery by generating molecules, screening vast libraries, and improving safety predictions, enabling faster, cost-efficient identification of effective drug candidates with higher hit rates.

Quantum Machine Learning, using QLSTM and variational quantum circuits, improves drug retrosynthesis by predicting reactions with higher accuracy (80% vs. 70%), accelerating complex drug development and overcoming classical method limitations.

Quantum Neural Networks (QNNs) analyzing clinico-demographic and real-world data to forecast individual treatment effectiveness, supporting precision medicine and improving patient outcomes, with early studies showing promising results.

Quantum computing enhancing digital twins of biological systems, enabling faster, more detailed simulations for diagnostics, treatment planning, and research, improving accuracy, responsiveness, and supporting personalized medicine through hybrid classical-quantum models.

Quantum optimisation and machine learning accelerate genomic variant detection and prioritisation, enhancing genotype-phenotype mapping, improving disease understanding, and enabling faster discovery of diagnostic and therapeutic opportunities.

Quantum computing with hybrid algorithms like VQE and THC enhances electronic structure calculations, enabling accurate, faster modeling of complex drug–protein interactions and materials beyond classical methods, transforming drug design and material discovery efficiency.

Quantum computing modelling gene regulatory networks by representing genes as qubits, capturing complex interactions simultaneously, enabling more accurate inference of known and novel gene relationships, advancing biological understanding and health research.

Quantum optimisation enhances phylogenetic tree reconstruction by efficiently navigating vast combinatorial spaces, improving accuracy and scale. This advances understanding of genetic evolution, aiding disease tracking, diagnostics, and treatment development.

Quantum algorithms accelerate DNA and protein sequence alignment, overcoming classical computational limits. This enables faster genetic analysis, precision medicine, mutation detection, and large-scale genomic research, supporting breakthroughs in personalized healthcare and drug development.

Quantum algorithms like QAOA, Grover’s, and phase estimation enable efficient DNA sequence reconstruction, boosting genome assembly speed and accuracy, with potential applications in RNA and omics for advancing genetic research and disease understanding.

Optically Pumped Magnetometers (OPMs) enabling precise, comfortable fetal heart and brain monitoring, overcoming SQUID limitations, improving diagnosis of fetal arrhythmias, maternal conditions, and cognitive development, and potentially enhancing outcomes for both mother and fetus.

Quantum tissue oxygenation imaging using advanced sensors to noninvasively detect hypoxic tissue at millimeter resolution, enabling early diagnosis of ischemia, cancer, and other conditions, with bedside and outpatient applications.

Quantum sensor-based subcellular microscopes enabling highly sensitive 3D imaging of cellular temperature, magnetic, and electric fields, improving drug discovery, disease treatment, and multimodal biomedical data acquisition in living cells.

NV-based magnetometry enabling nanoscale NMR under ambient conditions, allowing high-resolution analysis of tiny samples, single cells, and proteins, advancing metabolomics, disease diagnosis, and drug discovery beyond traditional NMR limits.